Cargando…
Future prospects in the treatment of erectile dysfunction: focus on avanafil
The treatment of erectile dysfunction (ED) has been revolutionized in the last 15 years with the introduction of type 5 phosphodiesterase (PDE5) inhibitors. Their efficacy, safety, and ease of administration have made them first-line treatment for ED. This article reviews the current therapies avail...
Autores principales: | Alwaal, Amjad, Al-Mannie, Raed, Carrier, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210072/ https://www.ncbi.nlm.nih.gov/pubmed/22087063 http://dx.doi.org/10.2147/DDDT.S15852 |
Ejemplares similares
-
Avanafil for erectile dysfunction
Publicado: (2019) -
A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil
por: Evans, Jeffery D, et al.
Publicado: (2015) -
Avanafil for treatment of erectile dysfunction: review of its potential
por: Burke, Ryan M, et al.
Publicado: (2012) -
Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility
por: Katz, Eric G, et al.
Publicado: (2014) -
Avanafil for male erectile dysfunction: a systematic review and meta-analysis
por: Cui, Yuan-Shan, et al.
Publicado: (2014)